Search

Your search keyword '"Patient Education"' showing total 195 results
Start Over Descriptor "Patient Education" Publication Type Reviews
195 results on '"Patient Education"'

1. Crovalimab-akkz.

Subjects
*DRUG laws, *THERAPEUTIC use of monoclonal antibodies, *PHARMACEUTICAL arithmetic, *RISK assessment, *PATIENT education, *COMPLEMENT (Immunology), *PHARMACY information services, *MONOCLONAL antibodies, *INTRAVENOUS therapy, *NEISSERIA meningitidis, *HEMOLYTIC anemia, *DRUG interactions, *DOSAGE forms of drugs, *SUBCUTANEOUS injections, *DRUG labeling, *DISEASE risk factors
Abstract

The article offers information on Crovalimab-akkz, a humanized monoclonal antibody and a complement C5 inhibitor under the brand Piasky, and discusses its indications, its dosage and administration, drug interactions, and advice to patients in using the drug.

Published
2024
Full Text
View/download PDF

2. Respiratory Syncytial Virus Vaccine (mRNA).

Subjects
*VACCINE development, *PATIENT education, *INTRAMUSCULAR injections, *VACCINE effectiveness, *RESPIRATORY syncytial virus infections, *PHARMACY information services, *VIRAL vaccines, *DRUG interactions, *DOSAGE forms of drugs, *DRUG labeling, *PHARMACODYNAMICS
Abstract

The article offers information on mRESVIA respiratory syncytial virus vaccine from Moderna, and discusses its indications, dosage and administration, and cautions on its use.

Published
2024
Full Text
View/download PDF

3. Mavorixafor.

Subjects
*HEMATOPOIETIC agents, *CHEMOKINES, *DRUG toxicity, *COMBINATION drug therapy, *PATIENT education, *DRUG side effects, *LONG QT syndrome, *AGAMMAGLOBULINEMIA, *PHARMACY information services, *WARTS, *GENE expression, *DRUG interactions, *DOSAGE forms of drugs, *CELL receptors, *DRUG utilization, *PHARMACODYNAMICS, *ADOLESCENCE, *CHILDREN, *OLD age, *ADULTS, *PREGNANCY
Abstract

The article provides information on Xolremdi, a CXC chemokine receptor 4 antagonist from X4 Pharmaceuticals, and discusses its indications, dosage and administration, cautions on its use.

Published
2024
Full Text
View/download PDF

4. Cantharidin.

Subjects
*SKIN diseases, *COMMUNICABLE diseases, *CLINICAL drug trials, *CANTHARIDES, *ANTIVIRAL agents, *DRUG interactions, *PATIENT education, *DOSAGE forms of drugs
Abstract

The article reviews the Cantharidin topical antiviral agent from Verrica Pharmaceuticals.

Published
2023
Full Text
View/download PDF

5. Online resources for pancreatic cancer: In observance of Pancreatic Cancer Awareness Month, explore these helpful resources and share them with patients and their families.

Subjects
*HEALTH literacy, *PATIENT education, *HEALTH, *INFORMATION resources, *PANCREATIC tumors, *ASSOCIATIONS, institutions, etc., *ENDOWMENT of research, *HEALTH equity, *WEBINARS
Abstract

The article recommends several online resources for pancreatic cancer including Pancreatic Cancer Action Network (PanCAN) at pancan.org, National Pancreatic Cancer Foundation at www.npcf.us, and The Lustgarten Foundation at lustgarten.org.

Published
2024
Full Text
View/download PDF

6. ACIDIC ADVERSARY: Unveiling the magic of nanohydroxyapatite.

Author

Diaz, Jeannette

Subjects
*DENTAL care, *CARBONATED beverages, *PATIENT education, *TEETH injuries, *OINTMENTS, *ORAL hygiene, *HYDROXYAPATITE, *COMMERCIAL product evaluation, *TOOTH demineralization, *DENTIFRICES, *ACIDS, *NANOPARTICLES, *ORAL health
Abstract

The article features Remin Pro by Voco, a water-based dental cream offering the triple protection of sodium fluoride, nanohydroxyapatite, and xylitol to prevent dental erosion or demineralization.

Published
2024

7. Guiding patients to establish an effective oil pulling routine.

Author

Hale, Amanda

Subjects
*THERAPEUTIC use of essential oils, *PATIENT education, *DENTAL care, *SOCIAL media, *DENTAL hygienists, *AYURVEDIC medicine, *ORAL hygiene, *COMMERCIAL product evaluation, *TOOTH care & hygiene, *PSYCHOSOCIAL factors
Abstract

The article offers information on Guru Nanda's Oil Pulling Oral Rinse.

Published
2024

8. Fostemsavir Tromethamine.

Subjects
*DRUG interactions, *DOSAGE forms of drugs, *HIV infections, *HIV-positive persons, *HIV fusion inhibitors, *MULTIDRUG resistance, *PATIENT education, *SPECTRUM analysis, *PHARMACODYNAMICS
Abstract

The article presents information about Rukobia Fostemsavir tromethamine, a HIV fusion inhibitor from ViiV Healthcare including uses, dosage and administration, mechanism of action, and contraindications.

Published
2020
Full Text
View/download PDF

9. Belantamab Mafodotin-blmf.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *ANTINEOPLASTIC agents, *DRUG interactions, *DRUG monitoring, *DOSAGE forms of drugs, *INJECTIONS, *INTRAVENOUS therapy, *MONOCLONAL antibodies, *MULTIPLE myeloma, *PATIENT education, *PHARMACY information services, *DRUG approval
Abstract

The article offers information on the antineoplastic drug Blenrep (Belantamab Mafodotin-blmf) from GlaxoSmithKline LLC including its uses, dosage form and strength, mechanism of action, the precautions related to lactation, pediatric use, and renal impairment, and the common adverse effects.

Published
2020
Full Text
View/download PDF

10. Pegcetacoplan.

Subjects
*RETINAL degeneration, *DRUG interactions, *IMMUNOSUPPRESSIVE agents, *PATIENT education, *DOSAGE forms of drugs
Abstract

The article reviews the Pegcetacoplan drug for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD) from Apellis Pharmaceuticals.

Published
2023
Full Text
View/download PDF

11. Aducanumab-avwa.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *DRUG approval, *ALZHEIMER'S disease, *MONOCLONAL antibodies, *DRUGS, *DRUG interactions, *DRUG labeling, *PATIENT education, *CENTRAL nervous system, *DOSAGE forms of drugs
Abstract

The article features the Aduhelm aducanumab-avwa central nervous system antibody agent for Alzheimer's disease treatment from Biogen.

Published
2021
Full Text
View/download PDF

12. Harnessing digital media for enhanced patient engagement and outcomes.

Author

Parekh, Bela, Tarib, Imane, and Awdeh, Richard

Subjects
*PATIENT participation, *DIGITAL media, *PATIENT education, *EYE care
Abstract

The article discusses the use of digital media and smartphone applications in patient education in the field of eye care. It highlights the benefits of digital platforms like CheckedUp in enhancing patient engagement and understanding of their conditions. The article also mentions that patients have a preference for visual and interactive content, and digital media allows for personalized education based on the patient's condition and treatment plan. However, challenges such as digital literacy gaps and data security need to be addressed. The article emphasizes the importance of striking a balance between technology and maintaining the doctor-patient relationship. [Extracted from the article]

Published
2023

13. A global e‐learning initiative for pediatric diabetes and endocrinology: Introduction and description.

Author

Ng, Sze May, Beaufort, Carine, Becker, Dorothy, and Wolfsdorf, Joseph I.

Subjects
*ONLINE education, *ENDOCRINOLOGY, *INTERNET, *SERIAL publications, *DIABETES, *CLINICAL competence, *PATIENT education, *PROFESSIONAL associations, *COVID-19 pandemic
Abstract

The article previews the International Society for Pediatric and Adolescent Diabetes (ISPAD)-European Society for Paediatric Endocrinology (ESPE) electronic learning global web portal at www.espe-elearning.org.

Published
2021
Full Text
View/download PDF

14. The Hydrosonic Pro from Curaprox.

Author

AKYALCIN, SERCAN

Subjects
*ORTHODONTICS, *POSTOPERATIVE care, *PATIENT education, *OPERATIVE dentistry, *ORAL hygiene, *COMMERCIAL product evaluation, *TOOTHBRUSHES, *TOOTH care & hygiene
Abstract

The article evaluates the Hydrosonic Pro orthodontic toothbrushes from Curaprox.

Published
2023

15. New Drugs 2017 PART 2.

Author

Hussar, Daniel A.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *ANTIDOTES, *ANTIVIRAL agents, *COMBINATION drug therapy, *CURARE-like agents, *DRUG interactions, *DRY eye syndromes, *GOUT, *HEPATITIS C, *MONOCLONAL antibodies, *NEUROMUSCULAR blocking agents, *TYPE 2 diabetes, *NURSING practice, *PATIENT education, *PSORIASIS, *SELF medication, *CONTINUING education units, *URICOSURIC agents, *GLUCAGON-like peptide-1 agonists, *THERAPEUTICS
Abstract

The article offers information about the drugs approved by the U.S. Food and Drug Administration (FDA) as of July 2017, including Lixisenatide marketed as Adlyxin by Sanofi, Lesinurad marketed as Zurampic by Ironwood, and Ixekizumab marketed as Taltz by Lilly.

Published
2017
Full Text
View/download PDF

16. Natural Medicines.

Author

Yacobucci, Karen L.

Subjects
*ALTERNATIVE medicine, *DATABASES, *HEALTH, *PATIENT education, *WORLD Wide Web, *INFORMATION resources
Abstract

The article reviews the web site Natural Medicines, located at naturalmedicines.therapeuticresearch.com.

Published
2016
Full Text
View/download PDF

17. New Drugs 2016 PART 3.

Author

Hussar, Daniel A.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *DRUG therapy for asthma, *ADIPOSE tissues, *ALKALINE phosphatase, *ANTINEOPLASTIC agents, *ANTIEMETICS, *CANCER chemotherapy, *COMBINATION drug therapy, *CHIN, *CYSTIC fibrosis, *DRUG interactions, *DRUG monitoring, *DRUGS, *DRUG administration, *DOSAGE forms of drugs, *ESTERASES, *GENETIC techniques, *IMIDAZOLES, *IRRITABLE colon, *MONOCLONAL antibodies, *MYOCARDIAL revascularization, *PATIENT education, *RARE diseases, *PLASTIC surgery, *TRANSLUMINAL angioplasty, *CONTINUING education units, *PLATELET aggregation inhibitors, *NURSING interventions, *PHARMACODYNAMICS, *THERAPEUTICS
Abstract

The article offers information about drugs approved by the U.S. Food and Drug Administration (FDA) as of September 2016, including Eluxadoline with brand name Viberzi from pharmaceutical company Allergan, Rolapitant hydrochloride with brand name Varubi from pharmaceutical company Tesaro, and Cangrelor with brand name Kengreal from The Medicines Company.

Published
2016
Full Text
View/download PDF

18. New Drugs 2016 PART 1.

Author

Hussar, Daniel A.

Subjects
*BACTERIAL diseases, *DRUG therapy, *DRUG dosage, *STROKE prevention, *SUBCUTANEOUS injections, *ANALGESICS, *ANTICOAGULANTS, *ATRIAL fibrillation, *COMBINATION drug therapy, *CONSTIPATION, *DRUG interactions, *DRUG monitoring, *DRUGS, *ENZYME inhibitors, *HEART failure, *INSOMNIA, *INTRAVENOUS therapy, *MONOCLONAL antibodies, *NALOXONE, *NARCOTICS, *NEUROTRANSMITTERS, *ORAL drug administration, *PATIENT education, *PRODRUGS, *PSORIASIS, *PULMONARY embolism, *VENOUS thrombosis, *DRUG approval, *CONTINUING education units, *VALSARTAN, *CEFTAZIDIME, *PHARMACODYNAMICS
Abstract

The article evaluates drugs approved by the U.S. Food and Drug Administration as of April 2016 including sacubtril/valsartan or Entresto from Novartis for heart failure (HF), ivabradine hydrochloride or Corlanor from Amgen from HF, and naloxegol oxalate or Movantik from Astra-Zeneca for opioid-induced constipation.

Published
2016
Full Text
View/download PDF

19. AskSARA: a window on clients' unmet needs.

Author

Seward, Janet

Subjects
*CUSTOMER satisfaction, *INTERNET, *PATIENT education, *PEOPLE with disabilities, *PUBLIC health, *WORLD Wide Web, *EQUIPMENT & supplies
Abstract

The article reviews the online medical equipment advice tool for public located at www.asksara.dlf.org.uk, from the nonprofit organization Disabled Living Foundation (DLF).

Published
2015

20. New Drugs 2015 PART 2.

Author

Hussar, Daniel A.

Subjects
*HYPOGLYCEMIA, *THROMBOSIS prevention, *SUBCUTANEOUS injections, *ANTI-infective agents, *BLINDNESS, *BLOOD platelet aggregation, *CELL receptors, *COMMUNICABLE diseases, *DIABETES, *DRUG interactions, *DRUG monitoring, *DRUGS, *DRUG administration, *HYPOGLYCEMIC agents, *INFLAMMATORY bowel diseases, *INTRAVENOUS therapy, *METABOLIC regulation, *MONOCLONAL antibodies, *TYPE 2 diabetes, *NURSING practice, *ORAL drug administration, *PATIENT education, *SKIN diseases, *SLEEP disorders, *SOLUTION (Chemistry), *DRUG tablets, *CONTINUING education units, *PLATELET aggregation inhibitors, *GLUCAGON-like peptide-1 agonists, *DISEASE complications, *PHARMACODYNAMICS, *PREVENTION
Abstract

The article offers information several drugs which are approved by the U.S. Food & Drug Administration, including Tedizolid phosphate used for skin infection treatment, from Cubist, antidiabetic agent Empagliflozin from Boehringer Ingelheim and Lilly, and Vedolizumab for curing ulcerative colitis.

Published
2015
Full Text
View/download PDF

22. Topical treatments.

Subjects
*DERMATOLOGIC agents, *EPIDERMIS, *PHARMACEUTICAL gels, *OINTMENTS, *PATIENT education, *SKIN diseases, *CUTANEOUS therapeutics
Abstract

The article offers brief information on various topical treatments, which include Acnecide by Galderma (UK) Ltd., Aknemycin Plus by Almirall Ltd., and Dalacin T by Pfizer Ltd.

Published
2014

23. Vot-ER.

Author

Callaway, Jess

Subjects
*VOTING, *ELECTIONS, *HOSPITAL libraries, *INFORMATION resources, *PATIENT education, *RECORDING & registration
Abstract

The article reviews the web site Vot-ER, located at https://vot-er.org.

Published
2021
Full Text
View/download PDF

24. Tongue Sweeper Hygienist Pro.

Author

GROVER, ANGELA

Subjects
*ORAL hygiene, *PERIODONTITIS, *TONGUE, *PERIODONTAL disease, *ADVERTISING, *COMMERCIAL product evaluation, *BAD breath, *PATIENT education, *PATIENT compliance
Abstract

The article features the Tongue Sweeper Hygienist Pro, an upgraded tongue scraper from Tongue Sweeper USA.

Published
2022

25. Oncology Drug Reference Sheet: Belumosudil.

Author

Dickman, Erin

Subjects
*GRAFT versus host disease, *PROTEIN kinase inhibitors, *HEMATOPOIETIC stem cell transplantation, *PHARMACY information services, *PATIENT education, *PHARMACODYNAMICS
Abstract

The article reviews the belumosudil (Rezurock) kinase inhibitor drug for treating chronic graft-versus-host disease (GVHD) from Kadmon Pharmaceuticals.

Published
2022

27. Training for genetic counsellors.

Author

Begleiter, Michael L.

Subjects
*GENETIC counselors, *GENETIC disorders, *MEDICAL genetics, *COUNSELORS, *COUNSELING, *DISEASES, *TRAINING, *GENETIC counseling, *PATIENT education, *CERTIFICATION
Abstract

Genetic counsellors are uniquely trained to provide support, explanations and guidance to individuals or families who have been diagnosed with a genetic disorder. As our knowledge of the genetic basis of disease increases, so does our ability to diagnose it and so does the demand for appropriately trained genetic counsellors. Despite this growing demand, only a handful of countries provides formal courses in genetic counselling, whereas other countries leave genetic counselling in the hands of medical practitioners or medical geneticists. [ABSTRACT FROM AUTHOR]

Published
2002
Full Text
View/download PDF

28. Anesthetic gel's onset could be ideal for gingivitis procedure: Also, the 10-second toothbrush and 10 Foot Wave.

Author

MILLER, KIM

Subjects
*ANESTHETICS, *COMMERCIAL product evaluation, *GINGIVITIS, *PATIENT education, *TOOTH care & hygiene
Abstract

The article offers information on a variety of dental care products including GingiCaine Oral Anesthetic Gel from Gingi-Pak, electric rechargeable toothbrush from Amabrush and ViziLite Pro oral lesion screening system from DenMat.

Published
2017

31. Oncology Drug Reference Sheet: Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf Subcutaneous Injection.

Author

Dickman, Erin

Subjects
*THERAPEUTIC use of monoclonal antibodies, *DRUG approval, *INJECTIONS, *NURSING, *MONOCLONAL antibodies, *GLYCOSIDASES, *PHARMACY information services, *DRUG side effects, *PATIENT education, *BREAST tumors, *PATIENT safety, *ELDER care
Abstract

The article offers information on Genentech Inc.'s Phesgo drug for the treatment of advanced HER2-positive breast cancer, including administration and dosage, adverse events, and the gero-oncology considerations.

Published
2021

32. Tech Notes. Going digital with patient teaching.

Author

SHUSTACK, LISA

Subjects
*INFORMATION technology, *NURSES, *PATIENT education, *POSTOPERATIVE care, *WEARABLE technology, *OCCUPATIONAL roles, *PREOPERATIVE education, *HEALTH care reminder systems, *MOBILE apps
Abstract

The article presents a comparison of patient teaching-related digital applications (apps) for patients and nurses including Ella's Handwashing Adventure and mySugr Diabetes Tracker Log for patients, and Show Me and QR Codes for nurses.

Published
2019
Full Text
View/download PDF

33. Oncology Drug Reference Sheet: Relugolix.

Author

Backler, Chelsea

Subjects
*THERAPEUTIC use of antineoplastic agents, *ONCOLOGY nursing, *DRUG approval, *HORMONE antagonists, *ORAL drug administration, *ANTINEOPLASTIC agents, *DRUG-food interactions, *DRUG interactions, *GERIATRIC nursing, *PHARMACY information services, *PATIENT education, *PROSTATE tumors, *WORLD Wide Web, *PHARMACODYNAMICS, *ADULTS
Abstract

The article reviews the drug relugolix (Orgovyx) as treatment of advanced prostate cancer from Myovant Sciences, Inc.

Published
2021

34. Watch this! How patient education systems help with day-to-day activities.

Author

KATZENMAIER, MELISSA

Subjects
*COMMUNICATION, *DENTAL hygiene, *PATIENT-professional relations, *PATIENT compliance, *PATIENT education, *TIME management, *VIDEO recording
Abstract

The article reviews the CAESY patient education system from Patterson Dental Supply Co.

Published
2015

36. Using fluoride varnish to combat pandemic-related oral health risks.

Author

AUGER, AMBER

Subjects
*CAVITY prevention, *DRUG efficacy, *XYLITOL, *FLUORIDE varnishes, *ORAL diseases, *GINGIVAL hyperplasia, *PATIENT education, *COVID-19 pandemic
Abstract

The article features the Profluorid Varnish, a fluoride varnish that offers enamel protection.

Published
2021

37. The evidence for non-pharmacological therapy of hand and hip OA.

Author

Hagen, Kåre B., Smedslund, Geir, Moe, Rikke H., Grotle, Margreth, Kjeken, Ingvild, Kvien, Tore K., and Hagen, Kåre B

Subjects
*OSTEOARTHRITIS treatment, *HAND diseases, *PAIN management, *DISABILITIES, *EVIDENCE-based medicine, *EXERCISE therapy, *HAND, *HIP joint diseases, *JOINTS (Anatomy), *MEDICAL protocols, *OSTEOARTHRITIS, *PATIENT education, *RESTRAINT of patients, *SPLINTS (Surgery)
Abstract

Osteoarthritis (OA) is a leading cause of pain and disability worldwide. Evidence-based guidelines and recommendations for the treatment of OA consider non-pharmacological modalities as the cornerstone of modern OA management. Nonetheless, research evidence from clinical trials on non-pharmacological interventions for the treatment of hand and hip OA is scarce and considerably less than that for knee OA. In addition, research on non-pharmacological interventions for OA appears highly on the list of patients' research priorities. Thus, there is a clear mismatch between the available research evidence for non-pharmacological interventions for hip and hand OA and both the treatment guidelines and the interests of patients. [ABSTRACT FROM AUTHOR]

Published
2009
Full Text
View/download PDF

38. Oncology Drug Reference Sheet: Selpercatinib.

Author

Dickman, Erin

Subjects
*THERAPEUTIC use of antineoplastic agents, *LUNG cancer, *PATIENT education, *PATIENT monitoring, *PATIENT safety, *PHARMACY information services, *THYROID gland tumors, *PROTEIN-tyrosine kinase inhibitors, *DRUG approval
Abstract

The article reviews the selpercatinib (Retevmo) drug for RET-altered non-small cell lung cancer (NSCLC) and thyroid cancer from Lilly USA, LLC.

Published
2020

39. Smartphoning it in: New applications are turning cell phones into medical devices.

Subjects
*WIRELESS communications, *INGESTION, *DIABETES, *HYPERTENSION, *MEDICAL practice, *PATIENT education, *SLEEP, *TECHNOLOGY, *WALKING, *PEDOMETERS
Abstract

The article reviews several software applications for smart phones including the Calorie Counter by FatSecret, My Blood Pressure and Heart Rate, and Quick Medical Terminology by Simple Tree.

Published
2010

40. Best apps to get urologists through their day: Versatile tools provide instant access to guidelines, journals, and more.

Author

BASOURAKOS, SPYRIDON and TE, ALEXIS E.

Subjects
*URINARY organ disease diagnosis, *URINARY organ diseases, *CURRICULUM, *EMERGENCY medical services, *LEARNING strategies, *MEDICAL protocols, *MEDICAL practice, *PATIENT education, *HEALTH self-care, *UROLOGISTS, *WORLD Wide Web, *CONTINUING medical education, *STREAMING media, *ACCESS to information, *MOBILE apps, *THERAPEUTICS
Abstract

The article offers information on a variety of applications related to urology practice including the American Urological Association's AUA Guidance at a Glance, Societé Internationale d'Urologie (SIU) Academy App and PubMed4Hh.

Published
2018

41. Chapter 12.

Author

Coyner, Theresa

Subjects
PREVENTION of bites & stings, DISEASE vectors, DERMATOLOGIC nursing, INSECTS, NURSING, PATIENT education, SKIN care, TICK infestations
Published
2019
Full Text
View/download PDF

42. Burning Red Face.

Author

Amin, Mina and Jacob, Sharon E.

Subjects
DERMATOLOGIC agents, ECZEMA -- Risk factors, SKIN disease treatment, DRUG withdrawal symptoms, EXANTHEMA, PATIENT education, SKIN care, STEROIDS, TELEMEDICINE, DECISION making in clinical medicine, SYMPTOMS, THERAPEUTICS
Abstract

Teledermatology is a term to describe the provision of dermatologic medical services through telecommunication technology. This is a teledermatology case of a burning red face. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

44. Chapter 22.

Author

Coyner, Theresa

Subjects
DERMATOLOGIC nursing, PATIENT education, TEACHING aids, INFORMATION resources
Published
2018
Full Text
View/download PDF

45. Moisturization.

Author

Cadavona, John Jay P., Rimtepathip, Parin P., and Jacob, Sharon E.

Subjects
SKIN, DERMATOLOGIC agents, LIPIDS, OINTMENTS, SKIN care, ANATOMY
Abstract

Dry skin, or xerosis, is one of the most common skin conditions for which patients seek medical advice. This article summarizes the importance of maintaining moisture in the skin and discusses the biological mechanisms for moisture preservation and the functional components present in topical moisturizers. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

46. DRUG Watch.

Author

Aschenbrenner, Diane S.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *STROKE prevention, *SUBCUTANEOUS injections, *ANTICOAGULANTS, *BLOOD coagulation tests, *DRUG monitoring, *DRUGS, *DRUG administration, *MONOCLONAL antibodies, *ORAL drug administration, *PATIENT education, *PSORIASIS, *PULMONARY embolism, *VENOUS thrombosis
Abstract

The article offers brief information on the monoclonal antibody Secukinumab and oral anticoagulant Edoxaban.

Published
2015

47. High-Tech Engagement.

Author

DUNCAN, TERESA

Subjects
*DENTAL hygiene, *PATIENT education, *TECHNOLOGY, *TOOTHBRUSHES, *PRODUCT design, *MOBILE apps
Abstract

The article offers information about the Sonicare FlexCare Platinum Connected intuitive power brush with Smart Sensor technology and the application Sonicare App from technology company Philips.

Published
2016

48. Website aims to improve inhaler standards: Every 10 seconds, someone in the UK suffers a potentially life-threatening asthma attack, and every 5 minutes someone in the UK dies from lung disease. Many of these deaths are preventable, and correct inhaler device use is critical to good basic care

Subjects
*PATIENT education, *RESPIRATORY therapy equipment, *INFORMATION resources
Abstract

The article reviews an interactive website located at https://ukiginhalerstandards.educationforhealth.org, launched by Education for Health and the UK Inhaler Group in order to raise awareness of the importance of accurate inhaler technique among healthcare professionals.

Published
2017

49. DRUG Watch.

Author

Aschenbrenner, Diane S.

Subjects
*ESTROGEN replacement therapy, *OSTEOPOROSIS prevention, *CELL receptors, *CODEINE, *CONTROLLED release preparations, *DRUGS, *DRUG administration, *ESTROGEN, *PATIENT education, *PULMONARY hypertension, *SULFONAMIDES, *PERIMENOPAUSE, *DRUG approval, *SELECTIVE estrogen receptor modulators, *PHARMACODYNAMICS, *THERAPEUTICS, SULFONAMIDE drugs
Abstract

The article evaluates several drugs recommended and approved by the U.S. Food and Drugs Administration (FDA) including the Zohydro ER hydrocodone narcotic, Macitentan (Opsumit) endothelin-receptor blocker and Duavee estrogen drug.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results